MedTrace Logo

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

NCT01653392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2024-03-15

No results posted yet for this study

Summary

The purpose of this study is to determine if inadvertent receipt of the BioThrax vaccine during pregnancy is independently associated with adverse maternal, pregnancy, or infant health outcomes.

Conditions

  • Pregnancy Complications
  • Pregnancy Outcome
  • Congenital Abnormalities

Interventions

BIOLOGICAL

Observational Intervention

This is an observational study, therefore no interventions are specified.

Sponsors & Collaborators

  • Naval Health Research Center

    collaborator FED

  • Emergent BioSolutions

    lead INDUSTRY

Principal Investigators

  • Natalie Wells, MD · Naval Health Research Center

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01653392 on ClinicalTrials.gov